Syneos Health's Acquisition of RxDataScience to Help Boost Product Development

Acquisition Provides Expertise in Artificial Intelligence and Data Engineering, Enterprise Analytics, and Technology-Enabled Solutions to Help Customers Perform Better

FREMONT, CA: “We are thrilled to welcome the RxDataScience team to the Syneos Health family. Combining our end-to-end services and deep behavioral and therapeutic expertise with their AI and data-science capabilities will generate customer strategies to accelerate product development and time to market,” states Alistair Macdonald, CEO, Syneos Health. Syneos Health®, the first fully-integrated biopharmaceutical solutions company, takes over RxDataScience, a market leader in healthcare-focused data analytics, data management, and artificial intelligence (AI). Syneos Health and RxDataScience will collaborate to offer biopharma customers technology-enabled, insight-driven solutions to speed performance across the product lifecycle, from lab to market.

The acquisition expands the company's offering of advanced solutions beyond simple reporting to complex platforms for Augmented Intelligent Insights and Biopharma Analytics. RxDataSciences' product lifecycle solutions include scientific computing for research and development, patient journey management, decentralized trials, RWE, predictive analytics, and commercial market research. RxDataScience provides an expedited consulting model that utilizes an iterative approach to rapidly build and deliver advanced analytics solution prototypes in six- to eight-week sprints.

 “This acquisition boosts our ability to deliver strategic insights and technology-enabled solutions that address our customers' most complex data challenges,” adds Macdonald.

RxDataScience expands Syneos Health's data science capabilities by bringing new capabilities and deep expertise in data engineering and management, as well as advanced enterprise analytics, to accelerate product and customer performance commercialization, with the potential to significantly shorten clinical trials and modernize medical affairs and commercial programs.

"RxDataScience has dedicated its first five years to building a vision, talent and technology that address challenges in data management, data science and AI faced by biopharma companies," says Sayee Natarajan, CEO, and Co-Founder, RxDataScience. "We're excited to join Syneos Health, giving us a tremendous opportunity to scale our services, expand our market and offer solutions to a larger customer base. We're particularly excited to be part of an ecosystem built on innovation and an entrepreneurial approach for delivering novel solutions and new capabilities to customers."